These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3243205)

  • 21. L-dopa stimulation at growth hormone release in normal subjects and in patients with Sheehan's syndrome.
    Himathongkam T; Tiyapan A; Rajatanavin R; Pitchayayothin N
    J Med Assoc Thai; 1981 Jan; 64(1):19-25. PubMed ID: 7217816
    [No Abstract]   [Full Text] [Related]  

  • 22. [The L-DOPA-propranolol test for the evaluation of reserves in secretory growth hormone].
    Frisch H; Schober E; Stransky E
    Wien Klin Wochenschr; 1983 Aug; 95(16):566-8. PubMed ID: 6649642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sleep stages and growth hormone in manganese poisoning. Effects of L dopa].
    Aranda L; López G; Horiuchi K; Mena I; Court J
    Acta Neurol Latinoam; 1976; 22(1-4):42-9. PubMed ID: 232604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Potentialization of the action of tl-dopa on the secretion of growth hormone].
    Pombo M; Paz M
    Arch Fr Pediatr; 1976; 33(7):714-5. PubMed ID: 999443
    [No Abstract]   [Full Text] [Related]  

  • 26. [Somatropin secretion in chronic alcoholism: lack of response to stimulation with L-dopa and glucagon].
    Riesco J; Costamaillere L; Litvak J; Zlatar N
    Rev Med Chil; 1974 Jun; 102(6):443-6. PubMed ID: 4471413
    [No Abstract]   [Full Text] [Related]  

  • 27. Impaired responses of growth hormone and blood eosinophils to L-dopa in atopy [proceedings].
    Szczeklik A; Serwońska M; Pietoń R; Podolec Z; Sieradzki J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):703. PubMed ID: 749825
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
    Esquifino AI; Fernández-Ruiz JJ; Cebeira M; Agrasal C; Tresguerres JA; Ramos JA
    Rev Esp Fisiol; 1987 Dec; 43(4):463-8. PubMed ID: 3448711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stimulation of growth hormone by L-dopa in mental anorexia].
    Reville P; de Laharpe F; Thierry R; Marzouki M; Stephan F
    Lille Med; 1976; 21(7):549-52. PubMed ID: 994683
    [No Abstract]   [Full Text] [Related]  

  • 30. Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
    Perlow MJ; Sassin JF; Boyar R; Hellman L; Weitzman ED
    Dis Nerv Syst; 1972 Dec; 33(12):804-10. PubMed ID: 4668972
    [No Abstract]   [Full Text] [Related]  

  • 31. [Circadian variations in the plasma GH response to L-dopa stimulation in female obesity].
    D'Alessandro B; Bellastella A; Cafaro MR; De Luca R; Esposito V
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2333-6. PubMed ID: 610754
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of oral administration of L-dopa on the secretion of plasma growth hormone in subjects of pediatric age].
    Rigillo N; Dammacco F; Pentasuglia N; Zimbalatti F
    Minerva Pediatr; 1975 Apr; 27(15):908-14. PubMed ID: 1134455
    [No Abstract]   [Full Text] [Related]  

  • 33. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome.
    Garcia-Borreguero D; Larrosa O; Granizo JJ; de la Llave Y; Hening WA
    Sleep; 2004 Jun; 27(4):669-73. PubMed ID: 15283001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD; Lantigua R; Lee LA
    J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
    [No Abstract]   [Full Text] [Related]  

  • 35. [HGH response to dihydroxyphenylalanine (L-dopa) (author's transl)].
    Del Valle Núñez CJ; García Guerrero M; García De Pesquera F; Pérez Bryan J
    An Esp Pediatr; 1976; 9(2):174-9. PubMed ID: 937869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone refractory interval to levodopa stimulation.
    Parker KM; Eddy RL
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1188-91. PubMed ID: 932184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone secretion in Addison's disease.
    Crabbé J; Henquin JC; Lambert AE
    Ann Endocrinol (Paris); 1978; 39(2):165-6. PubMed ID: 210706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stimulation of growth hormone (HGH) with L-dopa].
    Gosselin L; Bolduc R; Verreault R
    Union Med Can; 1974 Sep; 103(9):1552-6. PubMed ID: 4439528
    [No Abstract]   [Full Text] [Related]  

  • 39. [Growth hormone secretion in patients with various types of diabetes mellitus and in healthy persons after L-dopa stimulation].
    Muszyński J
    Pol Arch Med Wewn; 1983; 69(4-5):341-50. PubMed ID: 6634455
    [No Abstract]   [Full Text] [Related]  

  • 40. [Free fatty acids (FFA) blocking growth hormone secretion induced by L-Dopa].
    Casanueva F; Villanueva L; Peñalva A; Rodríguez R; Vila T; Cabezas-Cerrato J
    Rev Clin Esp; 1979 May; 153(3):217-20. PubMed ID: 482694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.